pharma · Non-Hodgkin Lymphoma · Advanced Solid Tumors · ADCT
ADC Therapeutics
ADC Therapeutics SA
ADC Therapeutics trial registry — 34 ClinicalTrials.gov studies with program phase, status, and indication context.
Lausanne, Vaud, Switzerland, CH HQ
2011 Founded
272 Employees
Public company Type
ADCT · NYSE Ticker
Company details
- Status
- Public
- HQ
- Lausanne, Vaud, Switzerland, CH
- Founded
- 2011
- Employees
- 272
- Programs
- 30
- Drugs
- 15
- Patents
- 22
ADC Therapeutics clinical trials
Registry index of 34 ClinicalTrials.gov studies linked to ADC Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
ADC Therapeutics trial registry — 34 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for ADC Therapeutics.
-
ADCT-402-105 — Phase 1
Clinical update -
Loncastuximab Tesirine — Phase 2
Clinical update -
Loncastuximab Tesirine — Phase 2
Clinical update -
Loncastuximab Tesirine — Phase 2
Clinical update -
Loncastuximab Tesirine — Phase 3
Clinical update -
Loncastuximab tesirine — Phase 2
Clinical update -
Loncastuximab tesirine — Phase 2
Clinical update -
Loncastuximab tesirine — Phase 2
Clinical update
Trial registry
-
CTIS ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗